Company news
Idt Australia Limited (ASX:IDT) news
Every Idt Australia Limited press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
FY26 Appendix 4E and Annual Report
August 19, 2026
Upgrade to FY26 Guidance
July 21, 2026
March Quarter Update & Positive FY26 Guidance
April 28, 2026
1HFY26 Results Presentation
February 17, 2026
1HFY26 Results
February 17, 2026
1HFY26 Appendix 4D and Half Year Report
February 17, 2026
Q1 FY26 Market Update - Strategic Realignment
October 21, 2025
FY25 Appendix 4E and Annual Report
August 20, 2025
CEO Resignation & Trading Update
August 7, 2025
Trading Halt
August 4, 2025
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities
July 17, 2025
Agreement with NASDAQ-Listed Gelteq for Dedicated Facility
July 16, 2025
Quarterly Revenue Growth of 30% with $62M in Open Proposals
April 29, 2025
New $3.2M Contract Supports Australia's Largest API Plant
April 9, 2025
1HFY25 Results Presentation
February 24, 2025
1HFY25 Results
February 18, 2025
1HFY25 Appendix 4D and Half Year Report
February 18, 2025
Further Growth in Q2 - H1FY25 Revenue Expected to Jump 82%
January 27, 2025
Settlement of Loan Facility with ScotPac
January 23, 2025
IDT Secures new loan Facility with ScotPac
December 19, 2024
Termination of discussions with Mynd
November 12, 2024
Q1 FY25 Quarterly Unaudited Revenue Hits Two-Year High
October 20, 2024
FY24 Appendix 4E and Annual Report
August 25, 2024
IDT Secures New Contract with Sanofi Australia
August 9, 2024
Strong Q4 Pushes Full-Year Revenue Ahead of Guidance
July 29, 2024
IDT Despatches Entitlement Offer Booklet
June 12, 2024
Update on Indicative Proposal from Mynd
June 11, 2024
Correction - Entitlement Offer To Raise $7m at 9c Per Share
June 4, 2024
Entitlement Offer to Raise $7m
June 3, 2024
FY24 Market Update
May 20, 2024
Victorian Government Awards Key Grant to IDT
May 5, 2024
Q3 Update - Third Quarter Operating Revenue Jumps 48%
April 23, 2024
IDT Secures contract with Sanofi Australia
April 16, 2024
1HFY24 Results Presentation
February 21, 2024
1HFY24 Results
February 21, 2024
1HFY24 Appendix 4D and Half Year Report
February 21, 2024
2023 AGM Presentation
November 22, 2023
Further Growth Driven by All of IDTs Key Business Verticals
October 31, 2023
FY23 Appendix 4E and Annual Report
August 28, 2023
IDT raises $2 million via over-subscribed SPP
July 19, 2023
Strong Finish to FY23, IDT positioned for growth in FY24
July 10, 2023
Share Purchase Plan to raise up to $2 million
June 20, 2023
$5.0 million Share Placement
June 4, 2023
Investor Presentation
May 22, 2023
Continuous Growth in Quarterly Sales and Positive Outlook
April 26, 2023
IDT Achieves Key Milestone with TGA License Upgrade
March 27, 2023
Appointment of Permanent CEO
March 2, 2023
Appendix 4D and Half Year Report - 31 December 2022
February 22, 2023
IDT Australia Limited - CEO Change
September 14, 2022
IDT Australia Investor Highlights 2022
August 30, 2022